At one year the rates were 57.1%, 52.4%, and 37.3% ( P = 0.13) suggesting a possible trend towards a fibrin sealant benefit.
← all excerpts
Fibrin Sealant: The Only Approved Hemostat, Sealant, and Adhesive-a Laboratory and Clinical Perspective.
1
—
—